Reported / Possible Side Effects Mild, anecdotal: Occasional reports of mild headache, transient jitteriness, or injection-site reactions
Colorectal cancer kills almost 53,000 people in the U.S
Safety Considerations General Safety Profile Based on available data, both BPC-157 and TB-500 appear to demonstrate relatively favorable safety profiles, though this assessment is based on limited clinical data and long-term safety has not been evaluated through rigorous clinical trials
NAD+ restoration using pure exogenous NAD+ is often not practical due to its unstable nature and poor bioavailability to most cell types, so efforts have focused on oral supplementation with the NAD+ precursor compounds nicotinamide (NAM), nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN)
3: severe) (Strbe et al., 2021)
Once your medical questionnaire is reviewed and approved by a prescriber, you will be notified and asked to attend your appointment to receive the injection at the pharmacy